Abstract
Nowadays use of calixarenes and nanotubes are widely spread in the pharmaceutical industry. In this work, interaction of between calix[4]arene and nanotube (6, 6) with Fluorouracil drug are investigated. The DFT calculations have been performed using the Gauss view and Gaussian98 in B3LYP method and 6-31G (d) standard basis set at 298.15K. There are calculated length bond (Å), bond angel (deg), dihedral angel (deg), energy hyperconjucation, and total energy (KJ mol-1), moment dipole (Debye), occupancy between nanotube (6, 6) and calix[4]arene with anticancer drug in B3LYP/6-31G (d) method. These cases and medicines show that complex1 is more stable than complex1. The parameter of E2, gap energy and ∆E° in composite of nanotube- Fluorouracil are higher than calix[4]arene-Fluororacil; therefore, complex1is more stable.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The application of nanotechnology in disease treatment, diagnosis, monitoring, and in the control of biological systems at the single molecule or molecular assembly level is referred to as nanomedicine. The major goal of nanomedicine is the design of material capable of delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents [1–5]. The type of drug delivery system carbon nanotube discovery by Iijma in 1990S[6]. A nanotube can be thought of as a hexagonal network of carbon atoms that has been rolled up to make aseamless cylinder [7, 8]. Carbon nanotubes exhibit superior thermal [9], mechanical [10], and electrical properties [11] and are considered the most promising building block for manufacturing low-cost, high-performance nanostructured composite materials [12].
In the paper, complexation of between fluorouracil and nanotube (6,6)/calix[4]arene are investigated as drug delivery system. Calixarenes, crown ether, and cyclodextrin are group of organic macrocyclic agents that have cup like shape which are easily available through the cyclocondensation of para-substituted phenols with formaldehyde [13, 14]. One way to increase the aqueous solubility of drugs is to use complexing agents to form hast- guest complexes [15–17]. Calixarenes are promising materials for nanomedicine application in drug delivery systems. For example, hydrophilic derivatives have shown interesting levels of activity against bacteria [19], fungi, cancerous cells and enveloped viruses, but also against thrombosis or fibrosis diseases [10, 20–22]. Anti-cancer genes act in a dominant fashion: when ectopically over expressed, they specifically destroy tumor cells without harming normal cells. This cell destruction can come in various modes such as apoptosis, mitotic catastrophe followed by apoptosis or necrosis, and autophage. Anti-cancer genes have only recently emerged from studies on cancer cells [23–26]. Fluorouracil or 5-Fluoropyramidin-2,4(1H, 3H)-dion is used as anti- cancer drug. Fluorouracil is an analog of pyrimidine which has been used as an anti-cancer drug for 40 years. The structure of fluorouracil is observed in Figures 1a and 2. It is anti metabolite drug and acts in several ways, but principally as synthesis inhibitor. These days there are ways to deliver a drug in the body without side effects [27]. In this paper, we reported types of drug delivery system such as nanotube and calix[4]arene.
Results and discussion
The several computational tools of, such as Density Functional Theory (DFT), Car-Parrinello molecular dynamics simulations, and hybrid QM/MM approaches, can be used for calculations. Density functional quantum chemical calculations have recently provided a relatively consistent picture on base pair interaction energies and geometrics. This can lead to more detailed information on structure, charge distribution, and energetic of the base pair [28–31]. At present, quantum chemical is almost universally applicable to the interpretation of physical and chemical properties of various compounds [32]. Understanding the biochemical mechanism of a disease usually suggests the types of molecules required for new drugs. In all cases, the aim of using the computer for drug design is to analyze the interactions between the drug and receptor sites and to design drugs that give an optimal fit [33–35]. Figure 1 shows the optimized compound calix[4]arene, nanotube (6,6), fluorouracil, nanotube (6,6)-fluorouracil (complex 1), and calix[4]arene-fluorouracil (complex 2) by DFT method in level B3LYP/6-31G (d).
The highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO), [36], the HOMO-LUMO bond gap have been found as a measure of the structural stability properties [37]. The parameters of bond length (Å), natural bond orbital (NBO) and bond angle (deg), dihedral angle (deg), distances of analysed models of the nanotube (6, 6) and calix[4]arene are calculated by DFT at the level of B3LYP and 6-31G (d) standard basis set and are shown in Table 1. The DFT calculated geometric parameters for complex 1, and 2 are compared in Table 1. The bond lengths C30-C84/O84 calculated for complex 1, 2 at the DFT level range from 1.47 to 1.40 Å, at the B3LYP/6-31G (d) level.
The bond lengths calculated at for complex 1 (in ring nanotube), 1.44 Å and, for complex 2, 1.40 Å, are within the range (in ring calixarene). The bond lengths calculated for complex 1, 1.37 Å, and complex 2 are ranged 1.38 Å. The bond length is lower than bond length in complex 1 and 2. With that reason, there is more electronegativity of nitrogen than carbon.
The angles for N87-C91 = O94 are 123.41° and 123.77° for complexes 1 and 2. The angles for C84-C86 = O90 are 126.9° and 124.4° for complex 1, 2. The angles for C84-C86 = O90 is larger than the angel for N87-C91 = O94 in complexes 1 and 2. The interaction of between nonbonding and bonding pairs on the nitrogen atom of the angle are reduced in N87-C91 = O94.
The dihedral angles for for complex 1 and 2 range from −26.01° to 35.84° (in dihedral 6). The dihedral angles 1,2,3,4,5 and 6, are observed in Table 1 and Figure 3.
The calculations of the total energies, hyperconjoucation energy (E2) of the optimized structures, dipole moments (μ), occupancy and hybrid at B3LYP/6-31G (d) levels are presented in Tables 2 and 3. In Table 2, the Mulliken charges in donor atoms electronegative O84 and acceptor C30 are negative and positive, respectively. Complex 1 has gap of energy that is larger than complex 2; therefore, complex 1 is stable. In Table 2, it becomes obvious that the complex 1 has formed higher hyperconjugation energy than complex 2. Also, the results show that by increasing P part in hybrid of atoms, the occupancy decreases. The S orbital part in hybrid of carbon in complex 2 is more than the S orbital part in hybrid of in complex 1. Combined with the most of hyperconjugation energy is stable. The occupancy coefficient is smaller. Complex 1 is more stable than the complex 2. The hyperconjugation energy complex 1 at 37.34 is larger than that in complex 2. The hybrid orbital S of a compound is lower. Table 2 shows the HOMO and LUMO energies for complexes. By evaluating HOMO/LUMO gap energies, it is obvious that if the gap becomes bigger, the complex will be stable; therefore, complex 1 is more stable than the complexes. The results of the present work were obtained using DFT optimization and formation energy (∆E° f in KJmol-1) calculation at the B3LYP/6-31G (d) level. ∆E° f is calculated using the formula ∑E°product–∑E°reactant. ∆E° f values in complexes 1 and 2 are in the range of −13.275 and +46.902 KJmol-1; therefore, complex1 has lower formation energy than the others. The energy (kJ mol-1) and dipole moments (Debye) indicate the consistency between the two complex calculations in DFT method. The gap energies and total energy, ∑E2, HOMO and LUMO complexes 1, 2 were calculated using the B3LYP method and 6-31G (d) basis set. The total energy sum of energy transitional, energy rotational and energy vibration in level B3LYP/6-31G (d) for complexes 1, 2 was calculated. The obtained results are shown in Table 3.
Heat capacity is the measurable physical quantity that specifies the amount of heat required to change the temperature of body by a given amount. Translation, rotation, and a combination of the two types of energy in vibration (kinetic and potential) of atoms represent the degrees of freedom of motion which classically contribute to the heat capacity of matter, but loosely bound electrons may also participate. On a microscopic scale, each system particle absorbs thermal energy among the few degrees of freedom available to it, and at sufficient temperatures, this process contributes to the specific heat capacity that classically approaches a value per mole of particles that is set by the Dulong-Petit law. For quantum mechanical reasons, at any given temperature, some of these degrees of freedom may be unavailable, or only partially available, to store thermal energy. Quantum theory can be used to quantitatively predict the specific heat capacity of simple systems.
Conclusions
In this paper, the result shows that complex 1 between Nanotube (6,6) and fluorouracil is more stable than complex 2. Thus, complex 1 is a better conditioner for drugs than complex 2. NBO analysis shows larger gap energy in complex 1. Complex 1 has lower formation energy and is more stable than complex 2.
Methods
Investigation is carried out using a personal computer (Intel (R) Pentium (R) dual CPU with 2GB RAM). Nanotube-fluorouracilarene (with different atom number) which reacts with anti-cancer drug. In this paper, the drug delivery properties are investigated by NBO analysis and DFT method. The DFT calculations have been performed using the Nanotube modeler [38], Gaussview [39] and Gaussian 03 [40] using B3LYP method and 6-31G (d) standard basis set. NBO analysis [41, 42] calculations have been also performed for all composites using B3LYP method and the standard 6-31G (d) basis set. Complexes between calix[4]arenes and nanotube (6,6) with Fluorouracil drug are optimized, then bond length (Å), bond angel (deg), dihedral angel (deg), hyperconjucation energy, as well as total energy (KJmol-1), moment dipole (Debye), occupancy, total energy and HOMO/LUMO are investigated between nanotube (6, 6) and calix[4]arene with anti-cancer drug using B3LYP/6-31G (d) method. Nanotube/calix[4]arenes and fluorouracil reaction are shown in Equations 1 and 2.
References
Wong Shi Kam N, Jessop TC, Wender PA, Dai H: Nanotube molecular transporters: Internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 2004, 126: 6850–6851.
Colomer JF, Henrard L, Lambin P, Van Tendelool G: 2001. Phys. Rev. B 2001, 64: 1–7.
Moradi O, Zare K: Adsorption of Pb(II), Cd(II) and Cu(II) Ions in Aqueous Solution on SWCNTs and SWCNT–COOH Surfaces: Kinetics Studies. Fullerenes, Nanotubes, and Carbon Nanostructures 2011, 19: 628–652.
Pouton CW, Seymour L: Key issues in non-viral gene delivery. Adv. Drug. Deliv. Rev. 2001, 46: 187–203.
Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K: Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. U.S.A. 2006, 103: 3357–3362.
Iijima S: Helical microtubules of graphitic carbon. Nature 1991, 354: 56–58.
Yan CS, Mao HK, Li W, Qian J, Zhao Y, Hemley RJ: Ultrahard diamond single crystals from chemical vapor deposition. Physica Status Solidi (A) 2004,201(4):25–27.
Kalele S, Gosavi SW, Urban J, Kulkarni SK: Nanoshell particles: synthesis, properties and applications. Curr. Sci. 2006, 91: 8.
Wong Shi Kam N, Jessop TC, Wender PA, Dai H: Nanotube molecular transporters: Internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 2004, 126: 6850–6851.
Pastorin G: Crucial Functionalizations of Carbon Nanotubes for Improved Drug Delivery: A Valuable Option? Pharmaceut. Res. 2009, 26: 746–769.
Taft BJ, Lazareck AD, Withey GD, Yin A, Xu JM, Kelley SO: Site-specific 258 assembly of DNA and appended cargo on arrayed carbon nanotubes. J. Am. Chem. Soc. 2004, 126: 12750–12751.
Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand JP, Prato M, Kostarelos K, Bianco A: Functionalized carbon nanotubes for plasmid DNA 262 gene delivery. Angew. Chem. Int. Ed. 2004, 43: 5242–5236.
Asfari Z, Böhmer V, Harrowfield J, Vicens J: Calixarenes 2001. Dordrecht: ED; Kluwer; 2001.
Gungor O, Memon S, Yilmaz M: Synthesis of Alkyl Nitrile and Alkyl Benzonitrile Derivatives of Calix[4]Arene and Their Polymer Supported Analogues: A Comparative Study in Two-Phase Extraction Systems. J. Funct. Polym. 2005, 63: 1–9.
Gutsche CD, Bauer LJ: The conformational properties of calix[4]arenes, calix[6]arenes, calix[8]arenes, and oxacalixarenes. J. Am. Chem. Soc. 1985, 107: 6052–6059.
Faraji M, Zare K, Aghaei H, Farajtabar A, Asfari Z, Gharib F: Complexation of p-Sulphonato-calix[6]arene by Glycine, Glycyl-glycine, and Glycyl-glycyl-glycine in Aqueous Solution. J. Solution. Chem. 2012. 10.1007/s10953-012-9924-2
Gharib F, Zare K, Taghvaei S, Monajjemi M, Amiri A: Complexation of tri-o-propoyl-p-t-butyl calix[4]arene with alkali metal cations in carbon tetrachloride solvent. Main. Group. Met. Chem. 2003, 26: 255–258.
Gharib F, Zare K, Amiri A: Spectrophotometric studies of alkali metal ion complexes of p-tetrabutyl- calix[4]arenes. Russ. J. Inorg. Chem. 2004, 49: 1511–1514.
Gharib F, Osouleddini N, Zare K, Taghvaei-Ganjali S: Spectrophotometric studies of alkali and alkali earth metal ions complexes of mono amino derivative of calix[4]arene. Russ. J. Inorg. Chem. 2010, 55: 434–437.
Brunink JAJ, Verboom W, Engbersen JFJ, Reinhoudt DN, Harkema S: Synthesis and cation complexation selectivity of bis (syn-proximally) functionalized calix[4]arenes. Recl. Trav. Chim. Pays-Bas 1992, 111: 511–516.
Shirakawa S, Shimizu S: Dehydrative amination of alcohols in water using a water-soluble calix[4]resorcinarene sulfonic acid. Syn. Lett. 2008, 10: 1539–1542.
Liu YL, Liu L, Wang YL, Han YC, Wang D, Chen YJ: Calix[ n ]arene sulfonic acids bearing pendant aliphatic chains as recyclable surfactant-type Brønsted acid catalysts for allylic alkylation with allyl alcohols in water. Green. Chem. 2008, 10: 635–640.
Zhang YJ, Cao WX, Xu : Interaction of Sulfonated Calix[ n ]arenes with Rhodamine B and Its Application to Determine Acetylcholine in a Real Neutral Aqueous Medium J. Chin. Chem. 2002, 20: 322–326.
Dolg M: Recent progress in understanding chemical shifts. J. Chem. Phys. 2009, 115: 7348–7355.
de Dios AC, Oldfield E: Antimalarial drugs and heme in detergent micelles: an NMR study. Solid State NMR 1996, 6: 101–125.
Whitehead RP, Benedetti JK, Abbruzzese JL, Ardalan B, Goodwin JW, Balcerzak SP, Samlowski WE, Lenz H-Z, Macdonald JS: A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study. Inves. New. Drug. 2004, 22: 335–341.
Cornell GN, Cahow CE, Frey C, McSherry C, Beal JM: Clinical experience with 5-fluorouracil (NSC-19 893) in the treatment of malignant disease. Cancer Chemother. Rep. 1960, 9: 23–30.
Monajjemi M, Chahkandi B, Zare K, Amiri A: Study of the hydrogen bond in different orientations of adenine-thymine base pairs: an ab initio study. Biochem 2005, 70: 366–76.
Guo D, Liu Y: Calixarene-based supramolecular polymerization in solution. Chem. Soc. Rev. 2012, 41: 5907–5921.
Tirado-Rives J, Jorgensen WL: Performance of B3LYP Density Functional Methods for a Large Set of Organic Molecules. J. Chem. Theory. Comput. 2008, 4: 297–306.
Zeevaart JG, Wang L, Thakur VV, Leung CS, Tirado-Rives J, Bailey CM, Domaoal RA, Anderson KS, Jorgensen WL: Optimization of azoles as anti-human immunodeficiency virus agents guided by free-energy calculations. J. Am. Chem. Soc 2008, 130: 9492–9499.
Casabianca LB, Kallgren JB, Natarajan JK, Alumasa JN, Roepe PD, Wolf C, de Dios AC: Antimalarial drugs and heme in detergent micelles: An NMR study. Inorg, J: Biochem. 2009, 103: 745–748.
Abul Haider Shipar M: DFT Studies on Fructose and Glycine Maillard Reaction: Formation of the Heyns Rearrangement Products in the Initial Stage. J. Iran. Chem. Soc. 2011, 8: 433–448.
Delchev VB: Computational (DFT and TD DFT) study of the electron structure of the tautomers/conformers of uridine and deoxyuridine and the processes of intramolecular proton transfers. J. Mol. Model 2010, 16: 749–757.
Ramachandran KI, Deepa G, Namboori K: Research on computational chemistry and molecular modeling. In Computational Chemistry and 344 Molecular Modeling: Principles and Applications. Heidelberg: Springer; 2008:297–310.
Miehlich B, Savin A, Stoll H, Preuss H: Results obtained with the correlation energy density functionals of Becke and Lee–Yang and Parr. Chem. Phys. Lett. 1989, 157: 200–206.
Dalili N, Zare K, Gharib F, Shadmani N: Calixarenes or Nanotubes: Which are better in drug delivery? JNSC 2011, 2: 213–217.
. Nanotube Modeler. version 1.2.4 (2004–2005) http://www.jcrystal.com/products/wincnt/Nanotube
Frisch A, Nielsen AB, Holder AJ: GaussView User Manual. Wallingford: Gaussian Inc.; 2000.
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Zakrzewski VG, Montgomery JA, Stratmann RE, Burant JC, Dapprich S, Millam JM, Daniels AD, Kudin KN, Strain MC, Farkas O, Tomasi J, Barone V, Cossi M, Cammi R, Mennucci B, Pomelli C, Adamo C, Clifford S, Ochterski J, Petersson GA, Ayala PY, Cui Q, Morokuma K, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Cioslowski J, Ortiz JV, Baboul AG, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Gomperts R, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Gonzalez C, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Andres JL, Gonzalez C, Head Gordon M, Replogle ES, Pople JA: GAUSSIAN 03, revision B.02. Pittsburgh, PA: Gaussian Inc; 2003.
Glendening ED, Reed AE, Carpenter JE, Weinhold F: NBO version 3.1. Pittsburg, PA: Gaussian Inc; 2003.
Fernandez L, Viruela-Martin P, Latorre J, Guillem C, Beltrán A, Amorós P: Molecular precursors of mesostructured silica materials in the atrane route: A DFT/GIAO/NBO theoretical study. J. Mol. Struc: THEOCHEM 2007, 822: 89–102.
Acknowledgements
Both of authors are grateful to University of Science and Research Branch, Islamic Azad University, Tehran, Iran. We are grateful to Shahid Beheshti University, Tehran, Iran. We are grateful to Young Researchers and Elites Club, Rasht Branch, Islamic Azad University, Rasht, Iran for financial support.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KZ and NSH both contributed to this research work. Both authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Zare, K., Shadmani, N. & Pournamdari, E. DFT/NBO study of Nanotube and Calixarene with anti-cancer drug. J Nanostruct Chem 3, 75 (2013). https://doi.org/10.1186/2193-8865-3-75
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/2193-8865-3-75